INNOVATE Corp (NYSE: VATE) files 8-K on R2 Glacial® Skin growth

Rhea-AI Filing Summary

INNOVATE Corp. filed a current report to share a press release about one of its portfolio companies. On September 9, 2025, the company issued a release titled “INNOVATE’s Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation,” highlighting developments at R2 and its Glacial® Skin technology.

The press release is attached as Exhibit 99.1 and is treated as “furnished,” not “filed,” meaning it is not subject to certain liability provisions and is not automatically incorporated into other securities offerings unless specifically referenced. No new financial statements or major transactions are described in this report.

false0001006837TRUE00010068372025-09-102025-09-100001006837hchc:CommonStockParValue0001PerShareMember2025-09-102025-09-100001006837hchc:PreferredStockPurchaseRightsMember2025-09-102025-09-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): September 9, 2025

INNOVATE CORP.

(Exact name of registrant as specified in its charter)

Delaware			001-35210			54-1708481
(State or other jurisdiction of incorporation)			(Commission File Number)			(I.R.S. Employer Identification No.)

295 Madison Avenue, 12th Fl
New York,, NY						10017
(Address of principal executive offices)						(Zip Code)

Registrant’s telephone number, including area code: (212) 235-2691

Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol			Name of each exchange on which registered
Common Stock, par value $0.001 per share			VATE			New York Stock Exchange
Preferred Stock Purchase Rights			N/A			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 8.01. Other Events.

On September 9, 2025, INNOVATE Corp. (“INNOVATE” or the “Company”) issued a press release titled “INNOVATE’s Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation”. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d)    Exhibits

Exhibit No.			Description
99.1			Press release dated September 9, 2025, titled "INNOVATE’s Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation"
104			Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 9, 2025

			INNOVATE Corp. (Registrant)
			By:			/s/ Michael J. Sena
						Name: Michael J. Sena
						Title: Chief Financial Officer

FAQ

What did INNOVATE Corp. (VATE) report in this 8-K filing?

INNOVATE Corp. reported that it issued a press release titled “INNOVATE’s Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation,” and attached it as Exhibit 99.1.

What is the subject of INNOVATE Corp.’s Exhibit 99.1?

Exhibit 99.1 is a press release dated September 9, 2025, describing developments at INNOVATE’s portfolio company R2, including its Glacial® Skin product and its growth and global reach.

Are the press release and exhibits in this 8-K considered "filed" with the SEC?

No. Exhibit 99.1 is expressly stated as not being deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference into Securities Act filings unless specifically referenced.

Does this INNOVATE Corp. 8-K include new financial statements?

No. Under Item 9.01, the company lists only exhibits, including the press release and the cover page interactive data file, and does not provide new financial statements.

Who signed the INNOVATE Corp. 8-K related to the R2 press release?

The report was signed on behalf of INNOVATE Corp. by Michael J. Sena, who is identified as the Chief Financial Officer.

What exhibits are attached to this INNOVATE Corp. 8-K filing?

The filing includes Exhibit 99.1, the press release about R2 and Glacial® Skin dated September 9, 2025, and Exhibit 104, the cover page interactive data file.